Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Crabb
James Crabb, Arbrouth GB
| Patent application number | Description | Published |
|---|---|---|
| 20110247835 | Sequenced packing element system - A downhole retrievable dual directional isolation tool is provided. The down hole tool comprises a mandrel, a compressor concentric with the mandrel, and a packing element disposed around the mandrel, wherein a body section of the packing element is asymmetrical. | 10-13-2011 |
Jeffrey Crabb, Bristol GB
| Patent application number | Description | Published |
|---|---|---|
| 20100210841 | CHEMICAL PROCESS 632 - A process for preparing pharmaceutically active compounds of formula (I) or a salt thereof | 08-19-2010 |
Jeffrey Norman Crabb, Bristol GB
| Patent application number | Description | Published |
|---|---|---|
| 20080221323 | Production of Rosuvastatin Calcium Salt - An improved process for the manufacture of (E)-7-[4-(4-flurophenyl)-6-isopropyl-2-[methyl(methylsulfony)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid calcium salt, Formula (1), which is useful for the production of a pharmaceutical useful in the treatment of, inter alia, hypercholesterolemia, hyperlipoproteinemia and atherosclerosis, is described. | 09-11-2008 |
| 20100222373 | Crystalline Form of Bis [(E)-7-[4-(4-fluoro-phenyl)-6-isopropyl-2-[methyl(methyl-sulfonyl)amino] pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid] Calcium Salt - Two polymorphic forms of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt, processes for making them and their use as HMG Co-A reductase inhibitors are described. | 09-02-2010 |
| 20100228028 | PROCESSES FOR THE MANUFACTURE OF ROSUVASTATIN AND INTERMEDIATES - A process for the manufacture of a compound of formula (V), useful for making rosuvastatin, by a stereoselective aldol reaction is described. Novel intermediates and processes to make them are also described. | 09-09-2010 |
